Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911, a novel, potent, and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing SUVN-D4010, a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders and schizophrenia; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
Suven Life Sciences Dividend Announcement
• Suven Life Sciences announced a annually dividend of ₹1.50 per ordinary share which will be made payable on 2019-02-25. Ex dividend date: 2019-02-14
• Suven Life Sciences's trailing twelve-month (TTM) dividend yield is -%
Suven Life Sciences Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2019-02-14 | ₹1.50 | annually | 2019-02-25 |
2018-02-06 | ₹1.50 | annually | 2018-03-01 |
2017-02-08 | ₹1.00 | annually | 2017-03-03 |
2016-03-14 | ₹1.00 | annually | 2016-03-23 |
2015-07-23 | ₹0.60 | annually | 2015-09-13 |
2014-07-24 | ₹0.46 | annually | |
2013-08-01 | ₹0.30 | annually | 2013-09-12 |
2012-09-17 | ₹0.30 | annually | 2012-10-27 |
2011-08-01 | ₹0.25 | annually | 2011-09-12 |
2010-07-19 | ₹0.25 | annually | 2010-08-26 |
2009-09-14 | ₹0.25 | annually | 2009-10-22 |
2008-09-11 | ₹0.25 | annually | 2008-10-01 |
Suven Life Sciences Dividend per year
Suven Life Sciences Dividend growth
Suven Life Sciences Dividend Yield
Suven Life Sciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Suven Life Sciences stock? Use our calculator to estimate your expected dividend yield:
Suven Life Sciences Financial Ratios
Suven Life Sciences Dividend FAQ
Other factors to consider when evaluating Suven Life Sciences as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Suven Life Sciences stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Suven Life Sciences's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Suven Life Sciences publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Suven Life Sciences distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Suven Life Sciences are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Suven Life Sciences sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Suven Life Sciences distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Suven Life Sciences declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Suven Life Sciences's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Suven Life Sciences's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.